Related Experiment Video
Updated: Sep 21, 2026

Intravascular Delivery of Biologics to the Rat Kidney
Published on: September 1, 2016
Chronic renal ischemia: pathophysiologic mechanisms of cardiovascular and renal disease
John H Rundback1, Timothy P Murphy, Christopher Cooper
1Department of Radiology, New York Presbyterian Hospital/Columbia University Medical Center, New York, New York 10031, USA. jr2041@columbia.edu
Abstract:
Chronic renal ischemia caused by renal artery stenosis (RAS) elicits a complex biologic response. Although the traditional pathophysiologic pathways underlying renal ischemia have been well studied, there is emerging evidence that additional mechanisms may be responsible for producing many of the hemodynamic alterations and end-organ injury seen in patients with RAS, including persistent hypertension, renal insufficiency, and cardiac disturbance syndromes. A better understanding of these mechanisms may allow earlier identification of RAS, provide markers to predict the response to revascularization, or allow unique therapeutic targets for drug development. This and a subsequent article will explore the pathophysiologic and clinical implications of chronic renal ischemia.
Insights
Chronic renal ischemia from renal artery stenosis (RAS) involves complex pathways beyond traditional understanding. Investigating these mechanisms may improve RAS diagnosis, predict treatment response, and identify new drug targets.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Pathophysiology
Background:
- Chronic renal ischemia due to renal artery stenosis (RAS) is a significant clinical issue.
- Traditional understanding of renal ischemia has been established, but emerging evidence suggests additional pathophysiologic mechanisms.
- These mechanisms contribute to hemodynamic alterations and end-organ damage in RAS patients, including hypertension and renal insufficiency.
Purpose of the Study:
- To explore the complex pathophysiologic mechanisms underlying chronic renal ischemia in renal artery stenosis.
- To identify potential markers for predicting response to revascularization in RAS.
- To uncover novel therapeutic targets for drug development in managing RAS complications.
Main Methods:
- Review of existing literature on renal artery stenosis and chronic renal ischemia.
- Analysis of emerging evidence on non-traditional pathophysiologic pathways.
- Exploration of clinical implications and potential diagnostic and therapeutic strategies.
Main Results:
- Emerging evidence points to additional mechanisms beyond traditional pathways in RAS-induced renal ischemia.
- These mechanisms contribute to hypertension, renal insufficiency, and cardiac issues in RAS patients.
- Understanding these pathways is crucial for improved patient outcomes.
Conclusions:
- A comprehensive understanding of the pathophysiology of chronic renal ischemia in RAS is essential.
- Further research into these mechanisms can lead to earlier diagnosis and better treatment strategies.
- This knowledge may pave the way for novel therapeutic interventions for RAS and its complications.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Acute Kidney Injury II: Pathophysiology
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology

